Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

124
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
124
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

152
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Single-Dose Bundibugyo Virus Vaccine Protects Macaques Within 3 Days.

bioRxiv : the preprint server for biology·2026
Same author

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses.

Vaccines·2026
Same author

Bundibugyo Ebola in DR Congo and Uganda: community-centred response must be operational, not rhetorical.

The Lancet. Infectious diseases·2026
Same author

Potent in vitro antiviral activity of 4'-Fluorouridine against diverse orthohantaviruses including Andes virus.

Antiviral research·2026
Same author

Marburg virus disease: a comprehensive review.

Clinical microbiology reviews·2026
Same author

Targeted cleavage site mutations in the Gn precursor enable efficient generation of replication-competent rVSV-based surrogates for emerging nairoviruses.

Emerging microbes & infections·2026

Related Experiment Video

Updated: Jul 18, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.3K

Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting.

Armand Sprecher1, Robert Cross2, Andrea Marzi3

  • 1Médecins Sans Frontières, Brussels, Belgium.

The Journal of Infectious Diseases
|August 19, 2023
PubMed
Summary

Despite approved Ebola virus disease treatments, high fatality rates persist. Experts recommend a multinational consortium to standardize clinical trial protocols for filovirus outbreaks.

Keywords:
clinical trialsdisease outbreaksfilovirusestherapeuticsvaccines

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

18.1K
Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

9.6K

Related Experiment Videos

Last Updated: Jul 18, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.3K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

18.1K
Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

9.6K

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Approved Ebola virus disease (EVD) treatments and vaccines exist, but high case fatality rates persist.
  • Current countermeasures may not be effective against other filoviruses, highlighting a significant gap in preparedness.
  • Subject-matter experts convened at the 10th International Filovirus Symposium to address these challenges.

Purpose of the Study:

  • To discuss strategies for improving filovirus disease treatment and preparedness.
  • To identify key challenges in conducting clinical trials during filovirus outbreaks.
  • To propose a framework for multinational research collaboration.

Main Methods:

  • A meeting of subject-matter experts was convened during the 10th International Filovirus Symposium.
  • Discussions focused on investigational therapeutics, vaccine candidates, and combination strategies.
  • The primary challenge identified was the implementation of effective clinical trials during outbreaks.

Main Results:

  • Several promising investigational therapeutics and vaccine candidates were presented.
  • The critical challenge identified is the need for standardized, well-designed clinical trials for safety and efficacy during filovirus outbreaks.
  • A multinational research consortium involving at-risk countries was proposed as an ideal mechanism for protocol development and coordination.

Conclusions:

  • Standardized clinical trial protocols are essential for effective response across multiple filovirus outbreaks.
  • Establishing a multinational research consortium is crucial for negotiating protocol design and coordinating preparedness efforts.
  • A follow-up meeting in Africa was recommended to establish this consortium and advance filovirus research and preparedness.